Drug intelligence / Profile preview

Binapuxi granules

Development stage
Unknown
Lead developer
Xinjiang Yinduolan Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Binapuxi granules is a traditional Uyghur medicine product developed by the Xinjiang Uygur Autonomous Region Institute of Drug Research. It is formulated as granules for oral administration and is primarily indicated for the treatment of the common cold, specifically the 'heat-type' variant characterized by symptoms such as fever and cough. As a traditional herbal medicine, its therapeutic effect is derived from a combination of botanical extracts intended to clear heat and alleviate respiratory distress. The drug has been evaluated in a randomized, double-blind, placebo-controlled Phase 2 clinical trial in China to assess its efficacy, safety, and optimal dosage in patients with the common cold.

Brand names
binafuxi granules
Other names
比那甫西颗粒binapuxi granulesbina fuxi granules

Beyond the preview

Go deeper on Binapuxi granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Binapuxi granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call